Party: | Partia Zieloni (Poland), Bündnis 90/Die Grünen (Germany), déi gréng (Luxembourg) |
---|
R03: Green and science-based approach to cannabis law in Europe
Draft text
- AM-1-8 Oikologoi Prasinoi / Ecologist Greens
- AM-4-7 Groen
- AM-9-1 Groen
- AM-1-10 Vihreät - De Gröna
- AM-5-4 Vihreät - De Gröna
Cannabis is the most widely used drug worldwide. According to UNODC estimates
more than 4% of the adult population (aged 18 - 64) have used Cannabis in 2020.
In 2021, 22.2 million adult citizens of the European Union consumed cannabis.
According to the report by Hanway 55% of Europeans support legalising
recreational cannabis, while almost 30% of respondents are interested in trying
it. Yet, in the 21st century we still find ourselves in Europe which puts a lot
of stigma around users of all kinds of narcotics, including cannabis. The World
Health Organization (WHO) has been highlighting time and again that users should
not be punished.
As Greens, we rely on science and demand policies that put more importance on
fighting drug addiction than fighting personal and recreational use of drugs.
Luxembourg has announced its intention of legalising recreative cannabis use in
the 2018 governmental program. As a first step, a draft legislation has been
tabled in 2022 to allow homegrowing for personal use. A strategy for the
implementation of a national recreative cannabis sector, covering every step
from production to sales, is in development and expected to be presented in
spring 2023.Germany is also in the process of legalising cannabis, going as far
as the current restrictive EU legislation allows. The proposed draft intends, in
a first step, to decriminalise possession and homegrowing for personal use and
enables the establishments of Cannabis social clubs, through which members can
attain cannabis legally. In a second step, the commercial production,
distribution and sale is tested in model projects.
Thanks to the continuous work of scientists, we already know that cannabis not
only should be decriminalised but also destigmatised. Citizens deserve reliable
and accessible information on the positive effects of cannabis, as well as on
the side effects that might be experienced.
Hemp, which can be used for the production of textiles, clothes, insulation, and
can even be a substitute for plastic, makes it an invaluable resource in
striving for more ecological production. But due to the stigma and extremely
strict regulations the use of hemp in production has been stifled, as the
products differ only in the psychoactive component. This means that when growing
hemp a simple omission, or mistake can lead to a lengthy trial, or in worst
cases a prison sentence.
MEDICAL USE
- AM-40-1 Oikologoi Prasinoi / Ecologist Greens
- AM-35-1 Groen
- AM-36-1 Groen
- AM-36-2 Vihreät - De Gröna
- AM-36-3 Green Party of England and Wales
The positive effect of using cannabis for medical purposes is indisputable. It
has been scientifically proven that medical marijuana relieves all kinds of
pain, from post-traumatic to oncological pain. Marijuana plays an important role
in the treatment of neurological diseases such as multiple sclerosis, epilepsy,
Alzheimer's, and Parkinson's diseases. Studies suggest that medicinal marijuana
helps reducing the symptoms of cancer and its treatment. These studies have also
shown very positive results in replacing opioid pain treatments with medical
marijuana.
- AM-46-1 Oikologoi Prasinoi / Ecologist Greens
- AM-46-2 Groen
- AM-48-1 Groen
- AM-43-1 Vihreät - De Gröna
Even though the majority of European countries have legalised medical marijuana,
access remains limited and inconsistent. For instance, on the Croatian medical
market, there is just one cannabis medical product registered to contain
cannabidiol. If legal, medical cannabis remains inaccessible. And even
prescribed this medicine is often not refunded and can only be obtained in the
pharmacy as a full-pay medicine, which is the case in Poland, for example.
DRUG TRAFFICKING
It has been proven that introducing bans does not lead to improving the issue of
addiction. Legislative prohibition is supporting only the so-called “black
market”. Drug trafficking must continue to be sanctioned and drug dealers must
be brought to justice. While crime organisations are gaining lucrative earnings,
there are no complex and structural prevention measures. Where illegal, there is
no control over the market, no control over the quality, no content of the drug
neither the age of the buyer. Additionally, young people who cannot access
cannabis legally will often be exposed to a criminal environment. There is no
control over its production, which means that any substances can be added or
mixed with the cannabis to create addiction or additives, to increase the volume
of the drug, and the health risks related to that are unknown.
According to Europol estimation Europeans spend approximately 9 billion euro
each year to purchase marihuana. This, obviously, creates an enormous black
market. The regulation and implementation of regulatory control of the entire
cannabis supply chain is a pillar of a successful legalisation. It would also be
an important step to drain down the existing black market.
The use of cannabis was also speculated to serve as a “gateway”, claiming that
it increases the likelihood
of users engaging in subsequent use of harder and more harmful substances. This
hypothesis, however, has been disproven by recent studies.
DECRIMINALISATION
Freeing up police assets from pursuing drug use crimes in support of
investigating drug sales crimes will give a boost to investigating sales crimes
and thus will help combat drug sales and organised crime more effectively.
Police resources should be used for more alarming and urgent matters, rather
than chasing everyday users and enforcing a ban that is not going to stop the
use of cannabis.
If we put an end to the persecution of drug use, taxpayers’ money could be used
to finance addiction prevention measures and open up centers specialising in
spreading the knowledge on substance abuse.
The cannabis market, if legal, can create new jobs and will be a new source of
tax revenues.
Ultimately, controlled and legalised production, trade, and licensed retailers
would improve public health while protecting children.
SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES
Prohibition is not a solution for tackling addiction successfully. Therefore, we
should push for rehabilitation and treatment as the best ways to support people
that experience substance abuse. Services aiming at addiction treatment must be
public and accessible. It cannot and should not mean long waiting time or a
privilege for the rich. In place of expensive persecution we need structurally
designed drug abuse prevention programmes, addiction consultation, and
withdrawal programmes that are accessible to everyone.
Greens are committed to politically and structurally supporting high standard
drug policies that focus on regulating the market in a way that it is supporting
citizens in legally accessing cannabis, as well as providing them with fully
reimbursable medical products and decriminalising personal use in all European
countries.
The EGP calls on the national governments and the EU Commission to:
- AM-98-1 Groen
- AM-98-3 Vihreät - De Gröna
- AM-98-4 Federation of Young European Greens
- AM-98-5 Federation of Young European Greens
- decriminalise the recreational use of marijuana
- AM-99-1 Vihreät - De Gröna
- AM-99-2 Green Party of England and Wales
- AM-99-4 Federation of Young European Greens
- legalise medical marijuana cultivation
- ease regulations around hemp production
- make medical marijuana reimbursable in the health insurance system
- fund accessible substance abuse centers, additional consultation as well
as withdrawal programmes aimed at supporting citizens in need
- AM-107-1 Miljöpartiet de gröna
- AM-105-1 Groen
- AM-106-1 Groen
- AM-107-2 Vihreät - De Gröna
- AM-107-3 Europe Ecologie - Les Verts
- AM-107-4 Irish Green Party / Comhaontas Glas
- advocate for changing the relevant international and European legal
requirements, like the 2004 EU Council Framework Decision on illicit
trafficking in drugs and precursors or the 1990 Implementing Convention
for the Schengen Protocol
Amendments
- AM-1-8 (Oikologoi Prasinoi / Ecologist Greens)
- AM-1-9 (Oikologoi Prasinoi / Ecologist Greens)
- AM-1-10 (Vihreät - De Gröna)
- AM-4-7 (Groen)
- AM-5-4 (Vihreät - De Gröna)
- AM-9-1 (Groen)
- AM-10-8 (Oikologoi Prasinoi / Ecologist Greens)
- AM-11-1 (Vihreät - De Gröna)
- AM-15-1 (Vihreät - De Gröna)
- AM-24-1 (Vihreät - De Gröna)
- AM-26-1 (Groen)
- AM-27-1 (Groen)
- AM-29-1 (Groen)
- AM-35-1 (Groen)
- AM-36-1 (Groen)
- AM-36-2 (Vihreät - De Gröna)
- AM-36-3 (Green Party of England and Wales)
- AM-40-1 (Oikologoi Prasinoi / Ecologist Greens)
- AM-43-1 (Vihreät - De Gröna)
- AM-46-1 (Oikologoi Prasinoi / Ecologist Greens)
- AM-46-2 (Groen)
- AM-48-1 (Groen)
- AM-51-1 (Vihreät - De Gröna)
- AM-53-1 (Groen)
- AM-62-1 (Vihreät - De Gröna)
- AM-62-2 (Vihreät - De Gröna)
- AM-68-1 (Groen)
- AM-69-1 (Vihreät - De Gröna)
- AM-69-2 (Federation of Young European Greens)
- AM-70-1 (Federation of Young European Greens)
- AM-71-1 (Vihreät - De Gröna)
- AM-71-2 (Federation of Young European Greens)
- AM-84-1 (Federation of Young European Greens)
- AM-85-1 (Federation of Young European Greens)
- AM-86-1 (Groen)
- AM-91-1 (Europe Ecologie - Les Verts)
- AM-92-1 (Federation of Young European Greens)
- AM-97-1 (Green Party of England and Wales)
- AM-98-1 (Groen)
- AM-98-3 (Vihreät - De Gröna)
- AM-98-4 (Federation of Young European Greens)
- AM-98-5 (Federation of Young European Greens)
- AM-99-1 (Vihreät - De Gröna)
- AM-99-2 (Green Party of England and Wales)
- AM-99-4 (Federation of Young European Greens)
- AM-100-1 (Groen)
- AM-100-2 (Federation of Young European Greens)
- AM-101-2 (Groen)
- AM-101-3 (Vihreät - De Gröna)
- AM-103-1 (Die Grünen)
- AM-103-2 (Groen)
- AM-103-3 (Europe Ecologie - Les Verts)
- AM-105-1 (Groen)
- AM-106-1 (Groen)
- AM-107-1 (Miljöpartiet de gröna)
- AM-107-2 (Vihreät - De Gröna)
- AM-107-3 (Europe Ecologie - Les Verts)
- AM-107-4 (Irish Green Party / Comhaontas Glas)